Stay up-to-date with the latest Sciety news
Discover the latest updates on our company and investments in life science
PRESS RELEASE. The Swedish pharmaceutical company PharmNovo, which is developing a new type of drug for nerve pain, has raised SEK 67 million in a new share issue led by Sciety. Karolinska Development AB participated in the share issue with SEK 20 million. The new capital will be used to…
Read more
PRESS RELEASE. Capitainer, a Swedish MedTech company supplying reliable solutions for self-sampling of blood and plasma, has raised a further SEK 34 million with Sciety and its investment syndicate in a new share issue. The company will use the proceeds to fund additional product validations, sales, and marketing to meet…
Read more
NEW COMPANY AT SCIETY. Long waiting time for surgery, deficiencies in patient safety, and high costs for care related to surgery. Healthcare faces significant challenges in Sweden and internationally while the demands for quality-improving measures are increasing. A Swedish health-tech player with an IT solution implementing structure and systematics in…
Read more
PRESS RELEASE. Sciety recently made an investment of over SEK 58 million in the cell therapy company NEOGAP Therapeutics, which is developing personalised immunotherapy for the treatment of cancer. The new capital will be used for a clinical phase I/II trial in colorectal cancer with an estimated start in 2022.…
Read more
PRESS RELEASE. The Swedish biotechnology company Synartro, which is developing a novel, improved treatment for knee osteoarthritis, has successfully raised SEK 34 million with Sciety and its investment syndicate. The new capital will be used for the company’s first clinical trial expected to start in 2022. ”We greatly appreciate the…
Read more
PRESS RELEASE. The Swedish diagnostics company SAGA Diagnostics, which develops ultrasensitive liquid biopsy tests for early detection of cancer relapse and personalized cancer treatment, recently completed a share issue of SEK 106 million led by Segulah Medical Acceleration together with Sciety. Hadean Ventures, which invested in the company at an…
Read more
NEW COMPANY AT SCIETY. Osteoarthritis affects more than 320 million people globally and is a leading source of chronic pain and disability in Europe and the US. Only half of the patients receive adequate pain relief. Sciety is now financing a company whose drug candidate has the potential to provide…
Read more
EMPE Diagnostics, which has developed a rapid test for the diagnosis and resistance determination of tuberculosis, the world’s deadliest infectious disease, has recently completed a share issue of SEK 23.5 million with Sciety. The company has also received a grant of SEK 25 million from EU Horizon 2020. The new…
Read more
PRESS RELEASE. Capitainer, a Swedish Medtech company that supplies intelligent solutions for self-sampling of blood and plasma, recently completed a share issue of SEK 31 million with Sciety and its investment syndicate. The investors demonstrated strong interest, and the share issue was fully subscribed in two days. The new capital…
Read more
NEW COMPANY AT SCIETY. Most blood sampling is still performed by qualified healthcare personnel at care facilities, but new technology that enables simple and reliable home sampling is now changing the landscape. Sciety finances a Swedish company that is at the forefront of the technology shift. Blood sampling has an…
Read more